
Sign up to save your podcasts
Or
Janet Qi is the co-founder and CEO of Pureminds NeuroPharma, a drug development company focused on treating neurological disorders using psychedelic and small molecule clinical programs. Pureminds NeuroPharma holds a Health Canada approved drug license for controlled substances, allowing them to produce, sell, import, and export psychedelic compounds.
3.7
1313 ratings
Janet Qi is the co-founder and CEO of Pureminds NeuroPharma, a drug development company focused on treating neurological disorders using psychedelic and small molecule clinical programs. Pureminds NeuroPharma holds a Health Canada approved drug license for controlled substances, allowing them to produce, sell, import, and export psychedelic compounds.
12 Listeners
10 Listeners
20 Listeners
122 Listeners
3 Listeners
40 Listeners
3 Listeners
5 Listeners
2 Listeners